Key result
Synthetic elastic protein induces elastin synthesis and decreases aortic wall stiffness in elastin-haploinsufficient mice.
Why the study?
Alteration of elastic fibers causes cardiovascular dysfunction in elastin haploinsufficiency, prompting evaluation of a synthetic elastic protein mimicking tropoelastin domains as a potential treatment.
Does a synthetic elastic protein (SEP) improve arterial structure and function in elastin-haploinsufficient mice?
Does a synthetic elastic protein (SEP) improve arterial structure and function in elastin-haploinsufficient mice?
Answers are grounded in this paper and cite their sources.
A synthetic elastic protein shows potential as a biomimetic treatment to improve arterial structure and function in elastin-deficient conditions.
Elastic fibers, made of elastin (90%) and fibrillin-rich microfibrils (10%), are the key extracellular components, which endow the arteries with elasticity. The alteration of elastic fibers leads to cardiovascular dysfunctions, as observed in elastin haploinsufficiency in mice (Eln+/-) or humans (supravalvular aortic stenosis or Williams–Beuren syndrome). In Eln+/+ and Eln+/- mice, we evaluated (arteriography, histology, qPCR, Western blots and cell cultures) the beneficial impact of treatment with a synthetic elastic protein (SEP), mimicking several domains of tropoelastin, the precursor of elastin, including hydrophobic elasticity-related domains and binding sites for elastin receptors. In the aorta or cultured aortic smooth muscle cells from these animals, SEP treatment induced a synthesis of elastin and fibrillin-1, a thickening of the aortic elastic lamellae, a decrease in wall stiffness and/or a strong trend toward a reduction in the elastic lamella disruptions in Eln+/- mice. SEP also modified collagen conformation and transcript expressions, enhanced the aorta constrictive response to phenylephrine in several animal groups, and, in female Eln+/- mice, it restored the normal vasodilatory response to acetylcholine. SEP should now be considered as a biomimetic molecule with an interesting potential for future treatments of elastin-deficient patients with altered arterial structure/function.
No takes yet. Share an insight, caveat, or question.
Boëté et al. (2022) studied Elastin haploinsufficiency. Synthetic elastic protein (SEP) was evaluated on Aortic structure and function (elastin synthesis, wall stiffness, vasodilatory response). Treatment with a synthetic elastic protein induced elastin synthesis, thickened aortic elastic lamellae, and decreased wall stiffness in elastin-haploinsufficient mice.
Synapse has enriched 10 related papers. Consider them for comparative context: